The general impression after this congress is that good times are coming for cancer immunotherapy. After some antibody-based immune-therapies have successfully arrived to clinical practice, multitude of approaches are now in clinical trials. The first session was devoted to “a new look at the tumor-associated antigens”.
7 dic 2011
Report on the “ESCII/NIBIT Meeting 2011".
New Perspectives in the Immunotherapy of Cancer.
The general impression after this congress is that good times are coming for cancer immunotherapy. After some antibody-based immune-therapies have successfully arrived to clinical practice, multitude of approaches are now in clinical trials. The first session was devoted to “a new look at the tumor-associated antigens”.
Etiquetas:
A. Anel,
Cancer,
Cells,
Células,
Ciencia,
Congresos,
Inmunoterapia,
Investigación,
M. Villalba,
Proyecto CliNK,
Research,
Sciences,
SUDOE,
Terápias,
UNIZAR
1 dic 2011
Un libro de 456 páginas que se centra en las propiedades y usos de los dendrímeros y dendrones.
Anne-Marie Caminade una de nuestras componentes de la Corporación CliNK, dirige desde 2006 el grupo llamado, en la actualidad, "Dendrímeros y heteroquímica", uno de los grupos más importantes del "Laboratorio de Química de la Coordinación" (LCC) del Centro Nacional de Investigación Científica (CNRS), junto con Turrin Cedric-Olivier, Laurent Regis, Ouali Armelle, Beatrice Delavaux-Nicot ha editado el libro de título original "Dendrimers: Towards Catalytic, Material and Biomedical Uses".
Suscribirse a:
Entradas (Atom)